163 related articles for article (PubMed ID: 25078631)
21. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.
Suzuki S; Yamane T; Mohri M; Kaneko A
Ophthalmology; 2011 Oct; 118(10):2081-7. PubMed ID: 21715012
[TBL] [Abstract][Full Text] [Related]
22. Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review.
Smith SJ; Smith BD; Mohney BG
Br J Ophthalmol; 2014 Mar; 98(3):292-7. PubMed ID: 24187047
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.
Kiratli H; Koç İ; Varan A; Akyüz C
Eur J Ophthalmol; 2017 Jun; 27(4):423-427. PubMed ID: 28106239
[TBL] [Abstract][Full Text] [Related]
24. [Study on conservative treatment of retinoblastoma--effect of intravitreal injection of melphalan on the rabbit retina].
Ueda M; Tanabe J; Inomata M; Kaneko A; Kimura T
Nippon Ganka Gakkai Zasshi; 1995 Nov; 99(11):1230-5. PubMed ID: 8533651
[TBL] [Abstract][Full Text] [Related]
25. Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma.
Hsieh T; Liao A; Francis JH; Lavery JA; Mauguen A; Brodie SE; Abramson DH
PLoS One; 2020; 15(7):e0235016. PubMed ID: 32609726
[TBL] [Abstract][Full Text] [Related]
26. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
27. Exudative Retinal Detachment Following Intravitreal Chemotherapeutic Treatment for Retinoblastoma.
Kotlyar B; Shapiro M; Blair M
Ophthalmic Surg Lasers Imaging Retina; 2019 Apr; 50(4):248-252. PubMed ID: 30998248
[TBL] [Abstract][Full Text] [Related]
28. Blue toe syndrome as a complication of intra-arterial chemotherapy for retinoblastoma.
Sarici A; Kizilkilic O; Celkan T; Gode S
JAMA Ophthalmol; 2013 Jun; 131(6):801-2. PubMed ID: 23764710
[No Abstract] [Full Text] [Related]
29. Persistence of retinal function after intravitreal melphalan injection for retinoblastoma.
Brodie SE; Munier FL; Francis JH; Marr B; Gobin YP; Abramson DH
Doc Ophthalmol; 2013 Feb; 126(1):79-84. PubMed ID: 23143758
[TBL] [Abstract][Full Text] [Related]
30. Two-dose exposure of intra-arterial chemotherapy for group D retinoblastoma.
Hutchinson A; Kaliki S; Shields CL
J Pediatr Ophthalmol Strabismus; 2012 Mar; 49 Online():e15-8. PubMed ID: 22443587
[TBL] [Abstract][Full Text] [Related]
31. TOXICITY AND EFFICACY OF INTRAVITREAL MELPHALAN FOR RETINOBLASTOMA: 25 µg Versus 30 µg.
Liao A; Hsieh T; Francis JH; Lavery JA; Mauguen A; Brodie SE; Abramson DH
Retina; 2021 Jan; 41(1):208-212. PubMed ID: 32106160
[TBL] [Abstract][Full Text] [Related]
32. Supraselective injection of intraarterial melphalan as the primary treatment for late presentation unilateral multifocal stage Vb retinoblastoma.
Aziz HA; Boutrid H; Murray TG; Berrocal A; Wolfe SQ; Pina Y; Dorfman M; Moftakhar R; Fernandes CE; Reichbach J; Aziz-Sultan MA
Retina; 2010 Apr; 30(4 Suppl):S63-5. PubMed ID: 20224464
[TBL] [Abstract][Full Text] [Related]
33. Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol.
Valero García S; López Briz E; Escobar Cava P; Balaguer J; Pelufo A; Megías JE; Poveda Andrés JL
J Oncol Pharm Pract; 2013 Jun; 19(2):159-64. PubMed ID: 23014898
[TBL] [Abstract][Full Text] [Related]
34. Changes in Retinal Thickness on OCT from Intravitreal Melphalan.
Narala R; Kim JW; Lang P; Le BHA; Hendargo HC; Branco D; Berry JL
Ophthalmol Retina; 2019 Mar; 3(3):288-289. PubMed ID: 31014710
[No Abstract] [Full Text] [Related]
35. Alternative treatment for retinoblastoma: Intra-arterial chemotherapy with melphalan.
De Freytas A; Harto-Castaño M; Barranco H; Aviño J; Martinez-Costa R
Arch Soc Esp Oftalmol; 2015 Oct; 90(10):487-90. PubMed ID: 26008929
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of macular retinoblastoma with superselective ophthalmic artery infusion of melphalan.
Hadjistilianou T; Coriolani G; Bracco S; Gennari P; Caini M; Cerase A; Galimberti D; De Francesco S; De Luca M; Mastrangelo D
J Pediatr Ophthalmol Strabismus; 2014; 51(1):32-8. PubMed ID: 24308859
[TBL] [Abstract][Full Text] [Related]
37. Surface-Modified Melphalan Nanoparticles for Intravitreal Chemotherapy of Retinoblastoma.
Sims LB; Tyo KM; Stocke S; Mahmoud MY; Ramasubramanian A; Steinbach-Rankins JM
Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1696-1705. PubMed ID: 31009525
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
Muen WJ; Kingston JE; Robertson F; Brew S; Sagoo MS; Reddy MA
Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434
[TBL] [Abstract][Full Text] [Related]
39. Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients.
Xue K; Ren H; Meng F; Zhang R; Qian J
BMC Ophthalmol; 2019 Feb; 19(1):61. PubMed ID: 30808420
[TBL] [Abstract][Full Text] [Related]
40. Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium.
Materin MA; Kuzmik GA; Jubinsky PT; Minja FJ; Asnes JD; Bulsara KR
J Neurointerv Surg; 2013 Nov; 5(6):e42. PubMed ID: 23188789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
